LS
Leelyn Smith Portfolio holdings
AUM
$610M
This Quarter Return
+5.37%
1 Year Return
+13.61%
3 Year Return
+56.17%
5 Year Return
+93.44%
10 Year Return
–
AUM
$340M
AUM Growth
+$340M
(+1.1%)
Cap. Flow
-$13.7M
Cap. Flow
% of AUM
-4.03%
Top 10 Holdings %
Top 10 Hldgs %
42.88%
Holding
411
New
21
Increased
53
Reduced
141
Closed
50
Top Buys
| 1 |
Principal Financial Group
PFG
|
$1.89M |
| 2 |
Comerica
CMA
|
$1.88M |
| 3 |
Verizon
VZ
|
$1.85M |
| 4 |
Huntington Bancshares
HBAN
|
$1.46M |
| 5 |
Vanguard Mega Cap Growth ETF
MGK
|
$1.42M |
Top Sells
| 1 |
T Rowe Price
TROW
|
$2.21M |
| 2 |
Aflac
AFL
|
$1.83M |
| 3 |
Intel
INTC
|
$1.67M |
| 4 |
Technology Select Sector SPDR Fund
XLK
|
$1.32M |
| 5 |
AT&T
T
|
$1.32M |
Sector Composition
| 1 | Technology | 9.61% |
| 2 | Healthcare | 8.14% |
| 3 | Consumer Discretionary | 7.09% |
| 4 | Financials | 5.59% |
| 5 | Consumer Staples | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exxon Mobil
XOM
$477B
| $3.03M | 0.89% |
48,088
-1,108
| -2% | -$69.9K |
|
27
Eli Lilly
LLY
$661B
| $2.93M | 0.86% |
12,779
-358
| -3% | -$82.2K |
|
28
Mastercard
MA
$536B
| $2.93M | 0.86% |
8,034
-51
| -0.6% | -$18.6K |
|
29
Comcast
CMCSA
$125B
| $2.89M | 0.85% |
50,626
-584
| -1% | -$33.3K |
|
30
UnitedHealth
UNH
$279B
| $2.88M | 0.85% |
7,186
-363
| -5% | -$145K |
|
31
Starbucks
SBUX
$99.2B
| $2.84M | 0.84% |
25,364
-2,324
| -8% | -$260K |
|
32
Honeywell
HON
$136B
| $2.79M | 0.82% |
12,703
-27
| -0.2% | -$5.92K |
|
33
Boeing
BA
$176B
| $2.78M | 0.82% |
11,621
-640
| -5% | -$153K |
|
|
WBA
34
DELISTED
Walgreens Boots Alliance
WBA
| $2.61M | 0.77% |
49,694
-1,116
| -2% | -$58.7K |
|
35
Walmart
WMT
$793B
| $2.59M | 0.76% |
18,358
-498
| -3% | -$70.2K |
|
36
Stryker
SYK
$149B
| $2.58M | 0.76% |
9,918
+741
| +8% | +$192K |
|
37
Invesco QQQ Trust
QQQ
$364B
| $2.55M | 0.75% |
7,192
-2,209
| -23% | -$783K |
|
38
Merck
MRK
$210B
| $2.54M | 0.75% |
32,715
+4,796
| +17% | +$269K |
|
39
AbbVie
ABBV
$374B
| $2.52M | 0.74% |
22,393
-113
| -0.5% | -$12.7K |
|
40
General Dynamics
GD
$86.8B
| $2.51M | 0.74% |
13,347
+228
| +2% | +$42.9K |
|
41
Biogen
BIIB
$20.8B
| $2.47M | 0.73% |
7,125
-436
| -6% | -$151K |
|
|
42
Verizon
VZ
$184B
| $2.4M | 0.71% |
42,802
+32,978
| +336% | +$1.85M |
|
|
43
Comerica
CMA
$9B
| $2.3M | 0.68% |
32,168
+26,338
| +452% | +$1.88M |
|
44
Procter & Gamble
PG
$370B
| $2.2M | 0.65% |
16,282
+240
| +1% | +$32.4K |
|
45
Bristol-Myers Squibb
BMY
$96.7B
| $2.18M | 0.64% |
32,667
+510
| +2% | +$34.1K |
|
46
Johnson & Johnson
JNJ
$429B
| $2.13M | 0.63% |
12,899
-28
| -0.2% | -$4.61K |
|
47
3M
MMM
$81B
| $2.1M | 0.62% |
10,564
+282
| +3% | +$56.1K |
|
48
Coca-Cola
KO
$297B
| $2.07M | 0.61% |
38,334
+724
| +2% | +$39.2K |
|
49
Sysco
SYY
$38.8B
| $2.06M | 0.61% |
26,502
+470
| +2% | +$36.6K |
|
50
Pfizer
PFE
$141B
| $2.03M | 0.6% |
51,709
+707
| +1% | +$27.7K |
|